The Effect of Obesity on the α-Cell Response to Hyperglycemia in the Presence of Amino Acids
Diabetes · 01.11.2026 · 75 (11) · 2010-2020
DOI: 10.2337/db26-0502 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, online erschienen am 11.09.2026. Verfasst von Sneha Mohan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Amino Acids, Glucagon-Secreting Cells, Hyperglycemia, Obesity. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hyperglycemia in prediabetes is accompanied by increased amino acid (AA) concentrations and impaired suppression of glucagon secretion by glucose. It is unknown whether an abnormal response to AA contributes or hepatic steatosis exacerbates α-cell dysfunction. Therefore, lean participants and participants with obesity (with and without hepatic steatosis) were studied on two occasions in random order using a graded glucose infusion. Saline or an AA mixture was infused. The glucagon secretion rate (GSR) was derived from peripheral glucagon concentrations, and the change in glucose required to reduce GSR by 50% (G50) was calculated for each participant. AAs were measured during the experiment. On both occasions, experimental conditions produced a progressive rise in insulin secretion and an inverse exponential suppression of glucagon. G50 did not differ between groups in response to glucose alone. AA infusion did not change G50 in lean participants. G50 increased during AA infusion in participants with obesity with and without hepatic steatosis, leading us to report these participants as a single group. The relative change in AA concentrations across study days was generally similar between groups. We conclude that despite a normal response to glucose, obesity increases α-cell responses to AA in humans. Article Highlights The aim of this study was to understand the pathogenesis of α-cell dysfunction in prediabetes. The primary hypothesis was that α-cell responsivity to glucose (reduction of the glucagon secretion rate by 50%) is impaired by amino acid (AA) infusion. A secondary hypothesis was that this abnormal response is exacerbated by hepatic steatosis. AA infusion impaired α-cell suppression in response to rising glucose in participants with obesity, but not in lean participants, despite a normal response to glucose alone. This abnormal response was unaffected by the presence or absence of hepatic steatosis. It seems likely that an abnormal α-cell response to AAs precedes an abnormal response to glucose alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN.
- Department of Information Engineering, University of Padua, Padua, Italy.
- Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
ORCID-Profile: Sneha Mohan, Federica Boscolo, Hannah E Christie, Aoife M Egan, Michael D Jensen, Chiara Dalla Man, Adrian Vella
Zitieren
APA
Mohan, S., Boscolo, F., Christie, H. E., Egan, A. M., Bailey, K. R., Jensen, M. D., Nair, K. S., Dalla Man, C., & Vella, A. (2026). The Effect of Obesity on the α-Cell Response to Hyperglycemia in the Presence of Amino Acids. Diabetes, 75(11), 2010-2020. https://doi.org/10.2337/db26-0502
Vancouver
Mohan S, Boscolo F, Christie HE, Egan AM, Bailey KR, Jensen MD, et al. The Effect of Obesity on the α-Cell Response to Hyperglycemia in the Presence of Amino Acids. Diabetes. 2026;75(11):2010-2020. doi:10.2337/db26-0502
BibTeX
@article{Mohan2026,
author = {Mohan, Sneha and Boscolo, Federica and Christie, Hannah E and Egan, Aoife M and Bailey, Kent R and Jensen, Michael D and Nair, K Sree and Dalla Man, Chiara and Vella, Adrian},
title = {The Effect of Obesity on the α-Cell Response to Hyperglycemia in the Presence of Amino Acids},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {11},
pages = {2010--2020},
doi = {10.2337/db26-0502}
}
EUVIMED